Abstract:9‐amino‐8‐bromo‐3,4‐dihydroacridin‐1(2H)‐one (KY‐31) displayed relatively low toxicity and retained anti‐inflammatory activity with a higher selectivity index compared to 9‐aminacrine (9‐AA). It may exert its anti‐inflammatory effects through the nuclear receptor subfamily 4 group A member 1 (NR4A1)/Interleukin‐10 (IL‐10)/suppressors of cytokine signalling 3 (SOCS3) signaling pathway and inhibit the protein targets phosphodiesterase‐4 (PDE‐4) and p38 mitogen‐activated protein kinases (MAPK). These findings support further development and exploration of 9‐amino‐8‐bromo‐3,4‐dihydroacridin‐1(2H)‐one as a promising anti‐inflammatory compound for inflammatory conditions. 9‐aminacrine (9‐AA), an external antibacterial agent, possesses important bioactivities for the treatment of cancer, viruses, and prion diseases. Recent research has revealed that 9‐AA has anti‐inflammatory effects through the up‐regulation of nuclear receptor subfamily 4 group A member 1 (NR4A1), but it is highly cytotoxic. To mitigate its toxicity, three series of novel 9‐AA derivatives were synthesized. The toxicity of all compounds was assessed, and some of the less toxic compounds were tested for in vitro anti‐inflammatory activities, leading to the establishment of structure‐activity relationships. In particular, 9‐amino‐8‐bromo‐3,4‐dihydroacridin‐1(2H)‐one exhibited relatively low toxicity and retained anti‐inflammatory activity, with a higher selectivity index compared to 9‐AA (3.44 versus 0.68). Expression experiments of inflammatory mediators revealed that this compound not only inhibited the gene expression of pro‐inflammatory factors, but also promoted the gene expression of anti‐inflammatory factors. Preliminary mechanistic studies suggested that it exerted anti‐inflammatory effects through the NR4A1/Interleukin‐10 (IL‐10)/suppressors of cytokine signalling 3 (SOCS3) signaling pathway. Furthermore, molecular docking studies indicating that it may exhibit anti‐inflammatory activity by inhibiting the protein targets phosphodiesterase‐4 (PDE‐4) and p38 mitogen‐activated protein kinases (MAPK). Based on our data, 9‐amino‐8‐bromo‐3,4‐dihydroacridin‐1(2H)‐one with its low toxicity and anti‐inflammatory properties, holds promise for further development as an anti‐inflammatory agent.

N-[2-(5,5-dimethyl-1,3-dioxane-2-yl)ethyl]amino acids: their synthesis, anti-inflammatory evaluation and QSAR analysis.

Synthesis and Biological Activity of 3-[(4-sulfamoylphenyl)hydroxy Methylene]-5-methyl-2-oxindole-1-carboxamides

Synthesis and Anti-Inflammatory Activity of Α-Substituted P-(Methanesulfonyl)phenylpropenamides

Synthesis and Anti-inflammatory Activity of α-Substituted p-Methylsulfonylcinnamic Acids

Synthesis and Anti-inflammatory Activity of Nitric Oxidedonating α-Substituted p-(Methanesulfonyl)phenylpropenoic Acid Esters

Synthesis and Anti-Inflammatory Activity Evaluation of Novel 3-Alkyl-6-(4h-1,2,4-triazol-4-yl)-3,4-dihydro-2h-benzo[e][1,3]oxazine Derivatives

Design, synthesis, and bioactivity evaluation of novel amide/sulfonamide derivatives as potential anti-inflammatory agents against acute lung injury and ulcerative colitis

Design,synthesis,and Anti-Inflammatory Evaluation of a Series of Novel Amino Acid-Binding 1,5-Diarylpyrazole Derivatives

Synthesis and anti-inflammatory activity ofhydroxamic acid and acyl urea derivatives ofp-(methanesulfonyl)phenylpropenoic acids

[Synthesis and Anti-Inflammatory Activity of P-(Methanesulfonyl) Styrene-Linked Cyclic Ketone Derivatives].

Synthesis of Sinomenine's Derivatives and Their Analgesic and Anti-Inflammatory Quantitative Structure-Activity Relationships

Design, Synthesis, Biological Evaluation and Docking Study of A New Series of 9‐aminoacridine Derivatives as Anti‐inflammatory Agents

Toward the Development of Chemoprevention Agents. Part II: Chemo-enzymatic Synthesis and Anti-Inflammatory Activities of a New Class of 5-Amino-2-substitutedphenyl-1,3-dioxacycloalkanes

Synthesis and Biological Evaluation of Novel Carboxylic Acid DHA-Alkanolamine Derivatives As Anti-inflammatory Agents by Targeting Nur77

A Practical Synthesis of Amino Limonin/deoxylimonin Derivatives As Effective Mitigators Against Inflammation and Nociception.

Diastereoselective Synthesis of 3,4-Dihydropyran-3-carboxamides with in Vitro Anti-inflammatory Activity

Synthesis and in vitro anti‐inflammatory activity of novel dendrobine amide/sulfonamide derivatives

Bioisosteric Replacement in the Search for Biologically Active Compounds: Design, Synthesis and Anti-Inflammatory Activity of Novel [1,2,4]triazino[2,3-c]quinazolines

A Experimental Study on the Anti-inflammatory Activity and Gastrointestinal Lesions of Α-Substituted P-Methylsulfonylphenylpropenoic Acids

Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents.

Synthesis and Anti-inflammatory Analgesic Activities of 2-(2,6-dichlorophenylamino)-benzeneacetic Acid(3-nitroxymethyl) Phenyl Ester